Details for New Drug Application (NDA): 021090
✉ Email this page to a colleague
The generic ingredient in CYCLESSA is desogestrel; ethinyl estradiol. There are eight drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the desogestrel; ethinyl estradiol profile page.
Summary for 021090
Tradename: | CYCLESSA |
Applicant: | Aspen Global Inc |
Ingredient: | desogestrel; ethinyl estradiol |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL-28 | Strength | 0.1MG,0.125MG,0.15MG;0.025MG,0.025MG,0.025MG | ||||
Approval Date: | Dec 20, 2000 | TE: | AB | RLD: | Yes |
Expired US Patents for NDA 021090
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Aspen Global Inc | CYCLESSA | desogestrel; ethinyl estradiol | TABLET;ORAL-28 | 021090-001 | Dec 20, 2000 | ⤷ Sign Up | ⤷ Sign Up |
Aspen Global Inc | CYCLESSA | desogestrel; ethinyl estradiol | TABLET;ORAL-28 | 021090-001 | Dec 20, 2000 | ⤷ Sign Up | ⤷ Sign Up |
Aspen Global Inc | CYCLESSA | desogestrel; ethinyl estradiol | TABLET;ORAL-28 | 021090-001 | Dec 20, 2000 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription